Literature DB >> 12916908

The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.

Michael M Leane1, Iain Cumming, Owen I Corrigan.   

Abstract

The objective of this work was to apply artificial neural networks (ANNs) to examine the relative importance of various factors, both formulation and process, governing the in-vitro dissolution from enteric-coated sustained release (SR) minitablets. Input feature selection (IFS) algorithms were used in order to give an estimate of the relative importance of the various formulation and processing variables in determining minitablet dissolution rate. Both forward and backward stepwise algorithms were used as well as genetic algorithms. Networks were subsequently trained using the back propagation algorithm in order to check whether or not the IFS process had correctly located any unimportant inputs. IFS gave consistent rankings for the importance of the various formulation and processing variables in determining the release of drug from minitablets. Consistent ranking was achieved for both indices of the release process; ie, the time taken for release to commence through the enteric coat (T(lag)) and that for the drug to diffuse through the SR matrix of the minitablet into the dissolution medium (T9(0-10)). In the case of the T(lag) phase, the main coating parameters, along with the original batch blend size and the blend time with lubricant, were found to have most influence. By contrast, with the T(90-10 phase), the amounts of matrix forming polymer and direct compression filler were most important. In the subsequent training of the ANNs, removal of inputs regarded as less important led to improved network performance. ANNs were capable of ranking the relative importance of the various formulations and processing variables that influenced the release rate of the drug from minitablets. This could be done for all main stages of the release process. Subsequent training of the ANN verified that removal of less relevant inputs from the training process led to an improved performance from the ANN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916908      PMCID: PMC2750588          DOI: 10.1208/pt040226

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  7 in total

1.  The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.

Authors:  Y Chen; T W McCall; A R Baichwal; M C Meyer
Journal:  J Control Release       Date:  1999-05-01       Impact factor: 9.776

2.  Application of neural computing in pharmaceutical product development.

Authors:  A S Hussain; X Q Yu; R D Johnson
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

3.  Pharmaceutical granulation and tablet formulation using neural networks.

Authors:  J G Kesavan; G E Peck
Journal:  Pharm Dev Technol       Date:  1996-12       Impact factor: 3.133

4.  Relating formulation variables to in vitro dissolution using an artificial neural network.

Authors:  N K Ebube; T McCall; Y Chen; M C Meyer
Journal:  Pharm Dev Technol       Date:  1997-08       Impact factor: 3.133

Review 5.  Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development.

Authors:  J Bourquin; H Schmidli; P van Hoogevest; H Leuenberger
Journal:  Pharm Dev Technol       Date:  1997-05       Impact factor: 3.133

Review 6.  Introduction to backpropagation neural network computation.

Authors:  R J Erb
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

7.  Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data.

Authors:  A S Hussain; R D Johnson; N N Vachharajani; W A Ritschel
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

  7 in total
  4 in total

1.  Experimental design for the formulation and optimization of novel cross-linked oilispheres developed for in vitro site-specific release of Mentha piperita oil.

Authors:  Wilbert Sibanda; Viness Pillay; Michael P Danckwerts; Alvaro M Viljoen; Sandy van Vuuren; Riaz A Khan
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

2.  Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development.

Authors:  Wendy I Wilson; Yun Peng; Larry L Augsburger
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

Review 3.  Digital Pharmaceutical Sciences.

Authors:  Safa A Damiati
Journal:  AAPS PharmSciTech       Date:  2020-07-26       Impact factor: 3.246

Review 4.  State-of-the-Art Review of Artificial Neural Networks to Predict, Characterize and Optimize Pharmaceutical Formulation.

Authors:  Shan Wang; Jinwei Di; Dan Wang; Xudong Dai; Yabing Hua; Xiang Gao; Aiping Zheng; Jing Gao
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.